Australia markets closed

Helix BioPharma Corp. (HBP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.55000.0000 (0.00%)
As of 07:51PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/07/2023
31/07/2022
31/07/2021
31/07/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,595
5,281
4,544
5,880
5,868
Selling general and administrative
384
299
595
1,686
2,719
Total operating expenses
5,929
6,326
6,040
9,132
8,616
Operating income or loss
-5,929
-6,326
-6,040
-9,132
-8,616
Interest expense
19
14
18
15
25
Total other income/expenses net
-422
3
-510
-90
55
Income before tax
-6,356
-6,290
-6,564
-9,575
-8,561
Income from continuing operations
-6,356
-6,290
-6,563
-9,574
-8,561
Net income
-6,356
-6,290
-6,563
-8,038
-8,985
Net income available to common shareholders
-6,356
-6,290
-6,563
-8,038
-8,985
Basic EPS
-
-
-
-
-0.07
Diluted EPS
-
-
-
-
-0.07
Basic average shares
-
-
-
-
127,712
Diluted average shares
-
-
-
-
127,712